Susquehanna International Group, LLP Olema Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$10.41 - $16.46 $84,321 - $133,326	-8,100 Reduced 33.06%	16,400 $195,000
Q2 2024 Aug 15, 2024	SELL	$8.73 - $13.99 $74,205 - $118,915	-8,500 Reduced 25.76%	24,500 $265,000
Q1 2024 May 07, 2024	SELL	$10.95 - $16.62 $329,595 - $500,262	-30,100 Reduced 47.7%	33,000 $373,000
Q4 2023 Feb 14, 2024	BUY	$10.53 - $17.14 $355,914 - $579,332	33,800 Added 115.36%	63,100 $885,000
Q3 2023 Nov 14, 2023	BUY	$8.19 - $12.98 $119,574 - $189,508	14,600 Added 99.32%	29,300 $361,000
Q2 2023 Aug 11, 2023	BUY	$3.22 - $9.65 $47,334 - $141,855	14,700 New	14,700 $132,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.88 $73,440 - $158,760	-27,000 Reduced 70.68%	11,200 $31,000

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $371M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.